Status:
UNKNOWN
Hypertonic Saline for COVID-19 Symptoms
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Coronavirus disease 2019 (COVID-19) is spreading rapidly in the world with no proven effective therapy to date. Some patients with COVID-19 develop sever respiratory disease requiring ICU ...
Detailed Description
Since its emergence as severe outbreak in China in December 2019, coronavirus disease 2019 (COVID-19) has spread so rapidly in the world that more than 780,000 cases have so far been reported worldwid...
Eligibility Criteria
Inclusion
- Age 18 years and older
- confirmed diagnosis of COVID-19 by PCR and
- Any of the following
- cough
- shortness of breath
- Respiratory rate more than 20 per minute or
- oxygen saturation 90% or less on room air
Exclusion
- Age younger than 18 years
- Pregnancy
- Participation in other COVID-19 intervention trial
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04465604
Start Date
February 1 2021
End Date
May 1 2022
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital and Research Center
Riyadh, Saudi Arabia